Skip to main content

Yes this stood out to me as well! Will be interesting to see how these types of technologies become incorporated into everyday clinical practise.

One thing that Dr. Gerszten mentioned in his publication, "Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery," was the idea of pattern recognition analysis. In practise, this means recognizing a pattern of peaks without necessarily knowing the underlying metabolites, and comparing this pattern with patterns known to represent disease states. A limitation of this type of analysis is that there isn't enough data yet to define the baseline pattern of a healthy individual versus someone living with CVD or DM, for example.

If metabolomics and proteomics do eventually become a part of your routine checkup, I could see that baseline quickly becoming established and the power of this type of pattern recognition could make it a common diagnostic protocol!

Name
Austin Read

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.